Literature DB >> 15021899

A link between p73 transcriptional activity and p73 degradation.

Liqing Wu1, Hongyan Zhu, Linghu Nie, Carl G Maki.   

Abstract

The p53 family of proteins includes three members, p53, p63, and p73. The levels and stability of p53 are controlled in large part by MDM2, which can bind the p53 N-terminus and promote its degradation. Because the MDM2 gene is transcriptionally activated by p53, it forms part of an autoregulatory feedback loop that directly links the transcriptional activity of p53 with its degradation. In contrast, little is known about the mechanisms that control p63 or p73 stability. In the current study, p73 deletion or point mutants that lacked transactivation activity were stable compared to wild-type p73. A naturally occurring p73 variant (DeltaNp73) was also stable compared to wild-type p73. Finally, fusion of the VP16-transactivation domain to an inactive, stable p73 mutant restored transactivation function and rendered the mutant protein unstable. These results demonstrate that p73 transactivation activity is necessary for rapid p73 turnover, and suggest that one or more transcriptional targets of p73 may promote its degradation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021899     DOI: 10.1038/sj.onc.1207538

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  Ubiquitin and ubiquitin-like modifications of the p53 family.

Authors:  Ian R Watson; Meredith S Irwin
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

Review 2.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

3.  DNA-binding and transactivation activities are essential for TAp63 protein degradation.

Authors:  Haoqiang Ying; Donny L F Chang; Hongwu Zheng; Frank McKeon; Zhi-Xiong Jim Xiao
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers.

Authors:  P Klanrit; P Taebunpakul; M B Flinterman; E W Odell; M A Riaz; G Melino; P Salomoni; J S Mymryk; J Gäken; F Farzaneh; M Tavassoli
Journal:  Oncogene       Date:  2009-07-13       Impact factor: 9.867

5.  Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin.

Authors:  Poramaporn Klanrit; Marcella B Flinterman; Edward W Odell; Gerry Melino; Richard Killick; James S Norris; Mahvash Tavassoli
Journal:  Cell Cycle       Date:  2007-11-16       Impact factor: 4.534

6.  P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.

Authors:  Lili Zhang; Linghu Nie; Carl G Maki
Journal:  Mol Cancer       Date:  2006-12-06       Impact factor: 27.401

7.  Regulatory feedback loop between TP73 and TRIM32.

Authors:  L Gonzalez-Cano; A-L Hillje; S Fuertes-Alvarez; M M Marques; A Blanch; R W Ian; M S Irwin; J C Schwamborn; M C Marín
Journal:  Cell Death Dis       Date:  2013-07-04       Impact factor: 8.469

8.  Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity.

Authors:  Zhonglei Lu; Frederick Bauzon; Hao Fu; Jinhua Cui; Hongling Zhao; Keiko Nakayama; Keiich I Nakayama; Liang Zhu
Journal:  Nat Commun       Date:  2014-03-17       Impact factor: 14.919

9.  Brdm2 - an aberrant hypomorphic p63 allele.

Authors:  Flaminia Talos; Sonja Wolff; Ulrike Beyer; Matthias Dobbelstein; Ute M Moll
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

10.  Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis.

Authors:  Melda Tozluoğlu; Ezgi Karaca; Turkan Haliloglu; Ruth Nussinov
Journal:  Nucleic Acids Res       Date:  2008-07-26       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.